| scholarly article | Q13442814 |
| P50 | author | Zahra-Soheila Soheili | Q40211284 |
| P2093 | author name string | Nader Sheibani | |
| Hamid Ahmadieh | |||
| Mozhgan Rezaei Kanavi | |||
| Shahram Samiei | |||
| Azam Mohammadian | |||
| Abouzar Bagheri | |||
| Shamila Darvishalipour Astaneh | |||
| P2860 | cites work | Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo | Q77959597 |
| Role of transforming growth factor-beta in transdifferentiation and fibrosis of lens epithelial cells | Q78106471 | ||
| Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix genes in the retina | Q80853963 | ||
| Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy | Q81343161 | ||
| Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration | Q83040839 | ||
| Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo | Q24554513 | ||
| Cellular and molecular mechanisms of fibrosis | Q24648892 | ||
| Matrix metalloproteinases | Q28140451 | ||
| The role of cathepsins in ocular physiology and pathology | Q28256335 | ||
| Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium | Q28359761 | ||
| NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues | Q28363601 | ||
| Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats | Q28571978 | ||
| Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. | Q30834539 | ||
| The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy | Q30845192 | ||
| A novel ex vivo angiogenesis assay based on electroporation-mediated delivery of naked plasmid DNA to skeletal muscle | Q33199034 | ||
| Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. | Q33223154 | ||
| N-hydroxy-7-(2-naphthylthio) heptanomide inhibits retinal and choroidal angiogenesis | Q33498560 | ||
| Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy | Q33703836 | ||
| Development of subretinal fibrosis after anti-VEGF treatment in neovascular age-related macular degeneration | Q33721103 | ||
| Lysosomal cysteine proteases: more than scavengers | Q33857460 | ||
| Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. | Q33931625 | ||
| Connective tissue growth factor: what's in a name? | Q34043152 | ||
| Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. | Q34062411 | ||
| Cell models to study regulation of cell transformation in pathologies of retinal pigment epithelium | Q34080190 | ||
| Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis | Q34105198 | ||
| Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition | Q35566836 | ||
| Matrix metalloproteinases and skeletal muscle: a brief review | Q35645268 | ||
| Fibrosis and diseases of the eye. | Q35649477 | ||
| Extracellular compartments in matrix morphogenesis: collagen fibril, bundle, and lamellar formation by corneal fibroblasts | Q36212167 | ||
| Ranibizumab treatment of patients with ocular diseases | Q36632913 | ||
| Vascular endothelial growth factor expression in choroidal neovascularization in rats | Q36864325 | ||
| Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition | Q37583186 | ||
| Growth factors as active participants in carcinogenesis: a perspective | Q37676697 | ||
| VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. | Q40001026 | ||
| VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression | Q40497297 | ||
| Expression of metalloproteinases from human retinal pigment epithelial cells and their effects on the hydraulic conductivity of Bruch's membrane | Q40753949 | ||
| Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease | Q41905147 | ||
| Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. | Q42502356 | ||
| Antifibrotic activity of bevacizumab on human Tenon's fibroblasts in vitro | Q43007261 | ||
| Connective tissue growth factor in indomethacin-induced rat gastric ulcer | Q44037280 | ||
| Identification of an Inhibitor of Neovascularization from Cartilage | Q44052793 | ||
| VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma | Q44068637 | ||
| Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells. | Q44082604 | ||
| AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat. | Q44295605 | ||
| VEGF164Is Proinflammatory in the Diabetic Retina | Q44417311 | ||
| Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab. | Q44520092 | ||
| A role for connective tissue growth factor in the pathogenesis of choroidal neovascularization | Q44578235 | ||
| Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation. | Q45964657 | ||
| MMP-2 and MMP-9 secretion by rpe is stimulated by angiogenic molecules found in choroidal neovascular membranes | Q46163874 | ||
| Pathophysiological consequences of VEGF-induced vascular permeability | Q46349878 | ||
| Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. | Q46727452 | ||
| Expression of connective tissue growth factor and its potential role in choroidal neovascularization | Q46736403 | ||
| Production and Activation of Matrix Metalloproteinase-2 in Proliferative Diabetic Retinopathy | Q47952325 | ||
| PlGF gene knockdown in human retinal pigment epithelial cells. | Q54400583 | ||
| TGF-β1 induces lens cells to accumulate α-smooth muscle actin, a marker for subcapsular cataracts | Q61927877 | ||
| Association of Connective Tissue Growth Factor With Fibrosis in Vitreoretinal Disorders in the Human Eye | Q63359126 | ||
| Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor | Q64380407 | ||
| Immunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration | Q67567101 | ||
| Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells | Q70764129 | ||
| Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes | Q71506583 | ||
| Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells | Q73038409 | ||
| Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro | Q74214063 | ||
| Transforming growth factor-beta 1 promotes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts | Q74431998 | ||
| Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis | Q77226536 | ||
| P921 | main subject | bevacizumab | Q413299 |
| P304 | page(s) | 378-390 | |
| P577 | publication date | 2015-04-10 | |
| P1433 | published in | Molecular Vision | Q6895981 |
| P1476 | title | Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cells | |
| P478 | volume | 21 |
| Q55078147 | CTGF Contributes to the Development of Posterior Capsule Opacification: an in vitro and in vivo study. |
| Q47096952 | Clinical and experimental study on angiopoietin-like protein 8 associated with proliferative diabetic retinopathy |
| Q41808036 | Effect of bevacizumab on the expression of fibrosis-related inflammatory mediators in ARPE-19 cells |
| Q64234996 | Extremely low frequency-pulsed electromagnetic fields affect proangiogenic-related gene expression in retinal pigment epithelial cells |
| Q49503028 | Involvement of the ubiquitin-proteasome system in the expression of extracellular matrix genes in retinal pigment epithelial cells. |
| Q50145564 | Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes. |
Search more.